InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2022-08-01 00:00:00 ET · period of report 2022-07-28 · accession 0001415889-22-008078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-08-01 2022-07-28 TECH Kummeth Charles R. CEO, Dir F - Tax $380.76 -27.7K 235.0K -11% -$10.55M
D 2022-08-01 2022-07-28 TECH Kummeth Charles R. CEO, Dir M - OptEx $108.49 +45.3K 262.7K +21% +$4.92M
D 2022-08-01 2022-07-28 TECH Kummeth Charles R. CEO, Dir M - OptEx $0.00 -45.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-28 F D 27,707 $380.76 235,042 D — — (F1) Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.
2 Common Common Stock 2022-07-28 M A 45,346 $108.49 262,749 D — — (F1) Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.
3 Derivative Stock Option (right to buy) 2022-07-28 M D 45,346 $0.00 0 D $108.49 · — to 2022-08-07 45,346 Common Stock (F2) Fully exercisable.